14th Annual Scientific Meeting Posters
Poster PDFs and abstracts are in alphabetical order by author.
Akiki-Intrinsic Connectivity Networks in Posttraumatic Stress Disorder: A Systematic Graph Theory Approach (Abstract)
Alphs-Empirical Evaluation of the SIBAT Using Categories Established by 3 Versions of the C-CASA (Abstract)
Arbatti-Foundations for a Patient-Reported Natural History of Early Parkinson Disease: Cross-Sectional Analysis of the MJFF Fox Insight (FI) Platform (Abstract)
Atkins-Assessment of iADL Functioning in Individuals with Subjective Cognitive Complaints Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) (Abstract)
Ballard-Clinical Predictors of Antisuicidal Response to Ketamine (Abstract)
Daniel-Does Variation in the Time of Day of PANSS Assessment Effect Symptom Severity? (Abstract)
Engelhardt-The Rater Applied Performance Scale: Evaluating Clinical Interview Skill via Audio Recordings of MADRS Assessments in a Clinical Drug Trial (Abstract)
Foff-A Phase 3 Study to Evaluate Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-Related Psychosis: Study Population and Design (Abstract)
Geerts-Why Do Amyloid-Modulating Clinical Trials Fail in Alzheimer’s Disease? A Critical Analysis Using Quantitative Systems Pharmacology (Abstract)
Goeldner-Assessing the Value of an IA Platform During the Screening Period to Evaluate and Predict Adherence to Study Drug Intake During Treatment in an Ongoing Proof Of-Concept Phase 2 Study in Schizophrenia (Abstract)
Goetghebeur-Cognitive Assessment in Oncology Patients Reveals Age-Sensitive Attentional Impairment and Deficits to a Neurogenesis Sensitive Measure: An Unmet Need? (Abstract)
Granger-Exploring Participant-Level Trajectories of Cognitive Performance in Patients with Schizophrenia (Abstract)
Gruber-EEG Spectral Fingerprinting as a New Method of Safeguarding Data Integrity in Multicenter Trials (Abstract)
Hassman-Can Subjects with Major Depression Learn about Key Placebo Response Factors: The Effect of an Educational Placebo Response Video (Abstract)
Jaeger-Cognitive Endpoints for Early Alzheimer’s Disease Trials: Development of the Early AD/ MCI Alzheimer’s Cognitive Composite (EMACC) (Abstract)
Josiassen-Estimands in a Schizophrenia Study (Abstract)
Khan Anzalee-PANSS Negative Symptom Dimensions Across Geographical Regions: Implications for Social, Linguistic and Cultural Consistency (Abstract)
Khan-Arif-The Magnitude of Placebo Response Over Time in Clinical Trials for Psychiatric and Other Chronic Medical Conditions (Abstract)
Kirkpatrick-Reliability Findings from the Unified Global Training Program for the Brief Negative Symptoms Scale (BNSS) (Abstract)
Kott-Association of PANSS Interview Duration with Data Quality-An Exploratory Analysis (Abstract)
Lytle-Engagement and Recruitment in the MOBILITY (Metformin for Overweight and OBese ChiILdren with Biopolar Disorders Treated with Second-Generation AntispsYchotics Study (Abstract)
Mariano-A Double-Blinded RCT of Transcranial Direct Current Stimulation for the Affective Symptoms of Chronic Low Back Pain (Abstract)
Murthy-Using Self-Reported Functioning Measures to Identify MDD Patients with Impaired Performance Based Functional Capacity (Abstract)
Østergaard-Simplified Negative and Positive Symptoms Interview (SNAPSI): An Abbreviated Assessment Technique for Schizophrenia Studies (Abstract)
Ramchandani-Utility of Human Laboratory Models for Screening of Pharmacotherapeutics for Alcohol Use Disorder: The Case of Varenicline (Abstract)
Revicki-Developing Clinically Meaningful Responder Thresholds for Primary Endpoints for Clinical Trials in Premenopausal Women with Hypoactive Sexual Desire Disorder (Abstract)
Sachs-Variation in Diagnostic Reliability Across MDD Clinical Trials (Abstract)
Sajatovic-Overcoming Obstacles to Implementation of an Interventional Clinical Trial on Chronic Psychotic Disorders in Tanzania (Abstract)
Seichepine-Comparison Between Flat and Enhanced Electronic Clinical Outcome Assessments of Mini-Mental State Attention and Calculation in Clinical Trials of Alzheimer’s Disease (Abstract)
Shiovitz-Don’t Change the Subject! The Changing Nature of Screened Subjects During Phase 3 Clinical Trials (Abstract)
Smigorski-Evolution of Alzheimer’s Disease Trial Characteristics: 2000 – 2017 (Abstract)
Smith-Exploring Novel Behavioral Tasks and Digital Phenotyping Technologies as Adjuncts to a Clinical Trial of BTRX-246040 (Abstract)
Stephenson-Global Regulatory Agencies Support Use of Dopamine Transporter Neuroimaging in Clinical Trials Targeting Early Parkinson’s Disease (Abstract)
Turkoz-Demonstration of the Relationships Among Clinical Global Impression of Severity of Depression Scale and Montgomery-Åsberg Depression Rating, Patient Health Questionnaire-9, and Sheehan Disability Scales (Abstract)
VanMeter-Use of a Prediction Algorithm for Randomized Stratification in an Amyotrophic Lateral Schlerosis Study (Abstract)
Zaragoza Domingo-Towards More Efficient Methods for Clinical Outcomes Assessment (COA) Instrument Selection in Clinical Trials (Abstract)